2027 Boston Society Gene and Cell Therapy Conference
March 4 - 5, 2027
Bristol Myers Squibb, 250 Water Street, Cambridge, MA 02141
***Download Conference Program***
Confirmed Speakers 2027
 |
PLENARY LECTURE Erik Sontheimer, PhD Pillar Chair in Biomedical Research & Professor @ UMass Chan Medical School, Vice Chair of the RNA Therapeutics Institute Prime Assembly With Linear DNA Donors Enables Large Genomic Insertions |
 |
PLENARY LECTURE Arthur Krieg, PhD Founder, President and Acting CEO/CSO @ Zola Therapeutics; Adjunct Professor @ Mass Chan Medical School; RNA Therapeutics Institute Advancing next-generation approaches to modulating immune cells - talk title TBA |
 |
Nagendra Chemuturi, PhD Sr. Director of ADME @ Eli Lilly & Company AOCs and ARCs - talk title TBA |
 |
Sourav Choudhury, PhD Distinguished Scientist, Group Head of Capsid Engineering & Immune Evasion in GMU @ Sanofi AAV capsids/re-engineered capsids - talk title TBA |
 |
Jonathon Winnay, PhD Head of Bioanalysis Sciences & DMPK @ Prime Medicine, Inc. Talk title TBA |
 |
Vasily Vagin, PhD Associate Director Bioanalytics @ Moderna BA strategies for mRNA vaccines - talk title TBA |
|
Vijayalakshmi Ramanan, MS, RAC Executive Director; Global Regulatory Affairs CMC @ City Therapeutics Novel siRNA modalities - talk title TBA |
 |
An Zhao, PhD Associate Director, Bioanalytical Sciences @ Regeneron Minimizing Immunogenicity Testing for Development of Oligonucleotide Therapeutics: A Risk-Basted Strategy |
|
2027 CONFERENCE THEME: ADVANCING THE NEXT GENERATION OF GENETIC MEDICINES
SCIENTIFIC PROGRAM HIGHLIGHTS
Session I: Next Generation Genetic Medicine & Emerging Therapeutic Modalities
Session II: Delivery Technologies & Engineering the Next Generation of Gene Therapies
Session III: Expanding Clinical Applications of Cell & Gene Therapies
Session IV: Translation, Manufacturing & Regulatory Science
Please Join our LinkedIn Group
